Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-042289

Director sold 4,000 shares at $40.00 ($160,000)

  • Director acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
GRIFFIN MICHELLE RENEE Director 2021-06-17 Option exercise +4,000 $7.80 $31,200 5,504 D: show line 1 in the form
GRIFFIN MICHELLE RENEE Director 2021-06-17 Sale −4,000 $40.00 $160,000 1,504 D: show line 2 in the form
Open-market sales · 4,000 sh · avg $40.00 · $160,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
GRIFFIN MICHELLE RENEE Director 2021-06-17 Option exercise · Stock Option (Right to Buy) −4,000 69,500 D: show line 3 in the form
Loading xslF345X03/doc4.xml…